Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed‐CD19 selective pressure
Authors:
Open Access
- 27 February 2019
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 186 (2) , 333-336
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaNew England Journal of Medicine, 2018
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2018
- Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysisBlood Cancer Journal, 2017
- PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genesGenes & Development, 2017
- Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironmentNature, 2016
- CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityNature Communications, 2016
- Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapyBlood, 2016
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyCancer Discovery, 2015
- Lineage switch in childhood acute leukemia: An unusual event with poor outcomeAmerican Journal of Hematology, 2012
- Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITDLeukemia, 2007